Business advisory firm KPMG UK has agreed an alliance with specialist research, innovation and investment agency Axillium to drive greater business investment in research and development (R&D).
Established in 2008, Axillium guides businesses through the innovation process from early stage R&D to delivery. The Midlands-based firm has supported nearly 200 organisations to move their innovation programmes forward and helped raise more than £210million in government grant funding.
KPMG works with businesses and organisations across the UK to help them access R&D incentives. The team works with clients to bid, access and manage UK government funding awards, but also identify and form partnerships with corporates, academia and supply chains to bring new intellectual property, products and services to market.
Steven Blacker, Partner in the Claims and Incentives Group at KPMG, said: “R&D incentives are really important in encouraging and rewarding businesses to overcome challenges in their field. Our work with Axillium is all about helping more businesses access and use the funding available to drive innovation and make those advances. Ultimately, this is in line with the Government’s Industrial Strategy to raise total R&D investment to 2.4% of the UK economy over the next eight years and bolster science and technology-led growth.”
Will Searle, Founder and Director of Innovation & Investment at Axillium, said: “Working together with KPMG across the UK is a major step in Axillium’s evolution. Together we will be able to expand our innovation management support to organisations of all sizes as they develop industrial-scale innovation challenges across growing markets.”